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ABSTRACT: In the last years, the debate on the therapeutic use of psychoactive drugs and 
compounds has intensified and has attracted a progressively growing body of research as well as 
of conferences and training courses. This is anticipated to revolutionize future mental health 
care. However, a medieval obscurantist climate remains that hinders further advances in the 
field. The research field of psychoactive drugs, despite its promises, is characterized by a 
number of challenges which, in the future, should be addressed, concerning, for instance, their 
potential therapeutic use. There is a concrete possibility to revitalize the use of these substances 
by bridging past and present, combining ancient knowledge and modern science to serve new 
therapeutic paradigms. 
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INTRODUCTION 
In the last years, the debate on the therapeutic use of psychoactive drugs and 
compounds has intensified and has attracted a progressively growing body of research 
as well as of conferences and training courses. Some researchers feel to live a true 
"psychedelic Renaissance" (Sessa, 2017), which is anticipated to revolutionize future 
mental health care, whereas other scholars perceive a still persisting medieval 
obscurantism limiting this "Renaissance bloom" (Miller, 2017). 
Psychotropic or psychoactive substances, as the term itself says, are able to act on 
the ordinary state of the psyche and, as such, to enable humans to experience non-
ordinary states of consciousness. In the ancient times, in the traditional cultures, this 
was achieved through the administration of plant derivatives and was considered as a 
highly respected, sacred practice to perform within a ritual context. 
Table 1. List of pioneers in the field of experimentation of psychoactive 
drugs and compounds.  
Pioneer in the field of 
psychoactive drugs 
Birth and death Notable work(s) 
Augustin Pyrame de 
Candolle 
1778-1841 A prominent Swiss botanist, 
author of books like “Historia 
Plantarum Succulentarum” and 
“Astragalogia” 
Ernst von Bibra 1806-1878 A German naturalist, 
author of “Plant Intoxicants: 
A Classic Text on the Use of 
Mind-Altering Plants” 
Richard Spruce  1817-1893 A British botanist 
specialized in bryology and 
explorer 
Mordecai Cubitt Cooke 1825-1914 A prominent British scholar 
of botany and mycology 
Paolo Montegazza 1831-1910 An Italian neurologist, 
physiologist, and 
anthropologist, he 
investigated the effects of 
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coca leaves 
Alphonse Trémeau de 
Rochebrune 
1836-1912 A French botanist, 
malacologist and a zoologist 
Ángelo Mariani 1838-1914 Italian, inventor of the first 
cocawine, Vin Mariani 
Stephen Powers  1840-1904  An American ethnographer 
William James  1842-1910 A prominent American 
philosopher and 
psychologist 
Louis Lewin 1850-1929 A German pharmacologist, 
he attempted the first 
systematic classification of 
psychoactive drugs with his 
book "Phantastica" (1924) 
Carl Hartwich 1851-1917 Author of “Die menschlichen 
Genussmittel” 
Karl Koller 1857-1944 An Austrian 
ophthalmologist, he 
introduced cocaine as a 
local anaesthetic for eye 
surgery 
Henry Havelock Ellis  1859-1939 A British psychologist, 
physician and writer, he 
experienced on himself the 
effect of mescaline 
John William 
Harshberger 
1869-1929 An American botanist 
specialized in plant 
geography, ecology 
Aleister Crowley 1875-1947 A well-known recreational 
drug experimenter 
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Alexandre Rouhier 1875-1968 Author of “Le peyotl la plante 
qui fait les yeux émerveillés” 
Kurt Beringer 1893-1949 A German psychiatrist and 
neurologist 
Aldous Huxley 1894-1963 A prominent English writer, 
novelist, and philosopher 
Max Rinkel 1894-1966 The first doctor in North 
America to work with LSD, 
he has been President of the 
Society of Biological 
Psychiatry 
Heinrich Klüver 1897-1979 A German psychologist 
Robert Gordon Wasson  1898-1986 Ethnomycologist  
Harold A. Abramson  1899-1980 An early advocate of 
therapeutic LSD 
Albert Hofmann  1906-2008 He synthesized and 
experienced on himself the 
effect of LSD 
Weston La Barre  1911-1996 American anthropologist 
and scholar in the field of 
ethnobotany 
Leo Zeff  1912-1988 An American psychologist 
and psychotherapist, he 
pioneered the use of LSD, 
ecstasy/MDMA, and other 
psychoactive drugs in 
psychotherapy 
Julius Axelrod  1912-2004 Prominent biochemist, he 
was awarded the Nobel 
Prize 
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John Cunningham Lilly  1915-2001 American physician, 
psychoanalyst, psychonaut, 
neuroscientist and 
philosopher 
Richard Evans Schultes 1915-2001 American biologist, he is 
considered the father of 
modern ethnobotany 
Ronald Arthur Sandison  1916-2010 A British psychiatrist and 
psychotherapist, he 
pioneered the use of LSD in 
psychiatry and clinical 
psychology 
Humphry Fortescue 
Osmond  
1917-2004 He invented the word 
psychedelic 
Abram Hoffer  1917-2009 A Canadian psychiatrist 
Oscar Janiger  1918-2001 Experimental psychiatrist 
and psychotherapist, he is 
known for his LSD research 
Athanasios Kafkalides 1919-1989 A Greek neuropsychiatrist 
Timothy Francis Leary  1920-1996 Author of “The Psychedelic 
Experience” 
Murray Elias Jarvik  1923-2008 He invented the nicotine 
patch 
Alexander Theodore 
"Sasha" Shulgin  
1925-2014 He resynthesized MDMA, 
and, after recognizing its 
potential for therapeutic 
use, gave it to a therapist 
friend, Leo Zeff 
Walter Norman Pahnke  1931-1971 A minister, physician, and 
psychiatrist, he is most 
famous for the "Good 
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Friday Experiment" 
Stanislav Grof 1931-today A Czech psychiatrist, one of 
the founders of the field of 
transpersonal psychology 
and a researcher into the 
use of non-ordinary states of 
consciousness 
Claudio Benjamín 
Naranjo Cohen  
1932-today A principal developer of 
Enneagram of Personality 
theories and a founder of 
the Seekers After Truth 
Institute 
Barbara Myerhoff  1935-1985  An American anthropologist 
Jack Sarfatti 1939-today An American theoretical 
physicist, specialized in the 
study of quantum physics 
and consciousness 
Andrew Weil 1942-today Founder and director of the 
Arizona Center for 
Integrative Medicine 
Terence Kemp 
McKenna  
1946-2000 An American ethnobotanist, 
mystic, psychonaut, 
lecturer, author, and an 
advocate for the responsible 
use of naturally occurring 
psychedelic plants 
Jonathan Ott  1949-today He has coined the term 
“entheogen” 
Dennis Jon McKenna 1950-today An American 
ethnopharmacologist, and 
research pharmacognosist 
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Giorgio Samorini 1957-today A free, independent scholar 
in the field of psychoactive 
drugs and compounds 
Julie Holland 1965-today An American 
psychopharmacologist, 
psychiatrist 
Patrick Lundborg  1967-2014 A writer on psychedelic 
culture and author of books 
like “Psychedelia” and “The 
Acid Archives” 
Patrick Karel Kroupa  1969-today A heroin addict from age 14 
to 30, he got clean through 
the use of the hallucinogenic 
drug ibogaine 
We do not want here to express a praise of the myth of the "good savage" or of the 
"good drug", but we would make a serious anthropological reflection on the use of 
"narcotic substances" that always accompany the life of human beings and even 
animals on the Planet Earth. 
With this regard, we can remember how in Europe drugs use was already present 
in the times of the Greeks before, and of the Roman Empire, subsequently. The 
Dionysian rites and the mysteries of Eleusi are historical examples of the use of 
psychoactive plants. 
Archaeological traces of the therapeutic, religious and ritual use of substances such 
as coca and psilocybin in South America are millennial and bring us to a reality that 
the Spanish conquest first and the prohibitionist policies then altered so much to lead 
the public to a distorted view of such substances as demonic plants or capable of 
leading to madness and death. 
In the East, cannabis, similarly, had a comparable fate: the first ascertained 
evidence of using this plant for therapeutic purposes dates back to the third millennium 
before Christ (BC) as described in the Nei-Ching text, written between 2700 and 2600. 
The plant was prescribed to treat diarrhoea, bronchitis, migraine, insomnia, appetite 
and nerve disorders. In India it is witnessed the use of cannabis in the second 
millennium in the sacred texts of the Vedas, where the demon of the nostrils Vide-
Vadat, is symbolized by hemp, which also has the function of favouring ecstasy. In 
India, hemp is called bhang and takes a significant religious meaning as it is the 
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favourite plant of Shiva God; his followers use it as a source of mystical inspiration. In 
the Indian religious literature, vijaya is called "victory" and in some Sanskrit scripts it is 
called indracarana or "God food". 
But "the food of the gods", including not only cannabis, but all psychoactive plants, 
are defined in the various traditions, are forbidden to humans. 
In the history of the Western civilization, prohibition begins its work of destroying 
use of psychotropic substances, stating that everything that alters the ordinary state of 
consciousness is potentially damaging and therefore prohibited. 
This decision taken by most, if not all of the Western states, has put a halt to 
psychotropic substances-related research that in the 1970s saw, for example, in the work 
of Richard Hoffman and of the chemist Richard Evans Schultes, a prestigious ethno-
botanist working at Harvard University, discoverer of the so-much discussed lysergic 
acid diethylamide (Lysergsäurediethylamid or LSD), as well as of many other scientists, the 
opportunity to go through the "Doors of Perception" (just to quote the title of the 1954 
Aldous Huxley’s essay). 
The doors of psychoactive substance research over the last 50 years have been 
closed and research has been relegated to some laboratories or practitioners who have 
continued experimenting and reporting their personal experiences, however, 
contributing to the scientific progress that calls up for designing investigation protocol, 
carrying out the experimentation and testing, following a strict, rigorous and 
statistically robust methodology. 
Meanwhile, data on anti-prohibition policies have shown that prohibition itself has 
not led to the diminution of abusive perpetuation in less secure and controlled spaces, 
nor to the possibility of discovering the therapeutic potential of the substances and 
their possible limits. 
Today, psychiatrists, neuroscientists, psychologists, anthropologists in Europe, the 
USA and South America, following the more or less rigid regulations of each state 
(Ardito et al., 2017; Firenzuoli et al., 2017; Gulluni et al., 2018; Re et al., 2015; Re et al., 
2016; Re et al., 2017), are progressively collecting the legacy of the previous researchers 
(Table 1) with the aim of strengthening research on psychedelics, negotiating a 
regulation for therapeutic and scientific uses and providing serious and legitimate 
information to the public. 
The substances currently undergoing clinical trials are cannabis, psilocybin, N,N-
dimethyltryptamine (DMT), ayahuasca, ecstasy (MDMA) and LSD. 
These are experimented against most common mental health pathologies, such as 
Post Traumatic Stress Disorder (PTSD), cancer-related anxiety, depression, cachexia, 
pharyngeal pain, multiple sclerosis and other organic disorders. 
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The research developed in the United States, Switzerland, England and Spain 
follows rigorous research protocols in which the mindset or set (the clinical and 
biographical history of the patient) plays a key role, the setting (the environment in 
which the experience is perceived) and the substance (typology, dosage, quality and 
quantity) play a major role. 
The treatment setting provides a cozy room with a sofa that is used during the 
session, a mask to cover visual stimuli, headphones linked to a piece of music chosen by 
the patient and two therapists, usually a physician and a psychotherapist who monitor 
the biological parameters of the person and are available for any need. The target 
involves inclusion or exclusion criteria/choices for research participation, pre- and 
post-session evaluations by administering tests and psychotherapy sessions to prepare 
before and, then, integrate the experiences lived during the session. 
Some patients report dissolution experiences of the Ego that, thanks to advanced 
and sophisticated neuro-imaging techniques, are associated with a marked decrease in 
activity in a brain area called “Default Mode Network” (DMN); this area seems to be 
overactive during episodes of rumination and rebirth, typical in depressive states, and 
plays an important role also in the ability of introspection and the development of 
mind theory, or the ability to "read" and interpret the emotions of others. 
Additionally, substances such as MDMA or Ayahuasca have empathic properties 
and are able to develop a state of trust and compassion, also allowing the emergence of 
ancient or removed memories, facilitating the processing of traumas and the possible 
treatment of addictions whose etiological cause/trigger is given by a traumatic 
event/component. 
However, because of regulatory concerns, sample sizes are small, given the 
difficulties involved in experimenting with substances. Like any other pharmakon, 
psychoactive substances may too lead, during or after administration, to the insurgence 
of adverse effects that, as in any experimentation, may and must be reported. However, 
the presence of suitably trained staff and a safe and secure context can be the 
ingredients to be able to proceed to an experimental process that freedom of research 
in science should provide to researchers. 
As such, the research field of psychoactive drugs, despite its promises, is 
characterized by a number of challenges which, in the future, should be properly 
addressed, concerning, for instance, their potential therapeutic use. There is a concrete 
possibility to revitalize the use of these substances by bridging past and present, 
combining ancient knowledge and modern science to serve new therapeutic 
paradigms. 
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